Inhibition of effector B cells by ibrutinib in systemic sclerosis
Jakob Einhaus(University of Tübingen), Dominik Schneidawind(University of Tübingen), Silke Duerr‐Stoerzer(University of Tübingen), Corina Schneidawind(University of Tübingen), Ann‐Christin Pecher(University Children's Hospital Tübingen), Elisa Asteriti(University of Tübingen), Reinhild Klein(University Children's Hospital Tübingen), Hildegard Keppeler(University of Tübingen), Kathy-Ann Secker(University of Tübingen), Hannes Schmid(University of Tübingen), Jörg Henes(University of Tübingen)
Cited by 42
Related Papers
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
|JAMA|2023|234
Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers
|Frontiers in Immunology|2018|103
Prevalence of autoimmune disease in women with premature ovarian failure
|The European Journal of Contraception & Reproductive Health Care|2019|77